Santosh K Bharti1, Paul T Winnard Jr.1, Louis Dore-Savard2, Yelena Mironchik1, Marie-France Penet1,3, and Zaver M Bhujwalla1,3
1JHU ICMIC Program, Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 2Experimental Therapeutics and Metabolism Program, McGill University Health Center, Montreal, QC, Canada, 3Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, United States
Synopsis
Tumor interstitial fluid (TIF) contains the
secretome of cancers that can impact most phenotypic aspects of cancer. One characteristic phenotype of pancreatic
ductal carcinoma (PDAC) is its ability to induce profound weight loss or
cachexia through a multifactorial syndrome that affects multiple organs. To understand the interaction between cancer
cells and body organs, here, for the first time, we have characterized the
metabolomic profile of TIF from cachexia and non-cachexia inducing pancreatic
cancer xenografts and identified clear differences in the metabolic secretome
between cachexia inducing and the non-cachexia inducing tumors.
Introduction:
Cachexia is an underexplored and yet devastating
consequence of cancer that is the cause of 20% of all cancer related deaths [1]. Cachexia
inducing tumors cause a ‘wasting away’ of the body. The condition is associated
with poor treatment outcome [2], fatigue, and extremely poor quality of life [2-3]. Because of the multi-factorial characteristics
of this condition, it has been difficult to understand the mechanisms driving
the impact of the tumor on body organs and the sequence of events that leads to
this lethal condition. Here we have used
1H MRS to characterize the metabolic profile of TIF obtained from
noncachexia (Panc1) and cachexia inducing (Pa04C) tumors to further understand
the impact of the deranged metabolism of cachexia-inducing tumors on the
metabolic secretome.Methods:
The
human pancreatic cancer cell line, Panc1, was obtained from ATCC. The human
pancreatic cancer cell line, Pa04C, was provided by Dr. Maitra [4]. Six to 8 week old male SCID mice were
inoculated in both the right and left flank with cancer cells (5×106,
Panc1 N=2, Pa04C N=2). We created a
collection chamber to collect TIF. The
chamber was implanted together with small tumor pieces harvested from the subcutaneous
flank tumors, into the subcutaneous flank space of SCID mice (Panc1 N=8 and
Pa04C N=6) until the tumor encompassed the chamber (4-5 weeks). The tumor was
then removed and the tumor tissue and TIF were collected. To obtain control TIF, an empty chamber was
implanted in the subcutaneous flank space of healthy mice. Dual phase solvent extraction was performed on
tumor tissue. The water phase was
separated, freeze dried, reconstituted in D2O PBS for spectral
acquisition. All 1H MR spectra were acquired on an Avance III 750
MHz (17.6T) Bruker NMR spectrometer equipped with a 5 mm broad band inverse
(BBI) probe. 1H MR spectra with water suppression were acquired
using a single pulse sequence with the following experimental parameters:
spectral width of 15495.86 Hz, data points of 64 K, 90° flip angle, relaxation
delay 10 sec, acquisition time 2.11 sec, 64 scans with 8 dummy scans, receiver
gain 80.6. Spectral acquisition,
processing and quantification were performed using TOPSPIN 2.1 software.Results and Discussion:
Representative spectra obtained from
interstitial fluid collected from normal mice, and from noncachexia inducing
Panc1 tumors, and cachexia inducing Pa04C tumors are shown in Figure 1. Representative spectra from Panc1 and Pa04C
tumor extracts are displayed in Figure 2.
A heat map display of 1H MRS metabolites from normal fluid
and Panc1 and Pa04C TIF is presented in Figure 3. A heat map display of 1H MRS
metabolites in extracts obtained from eight Panc1 tumors and six Pa04C tumors
is presented in Figure 4. Notable
differences between Pa04C compared to Panc1 TIF or normal interstitial fluid
were a significant decrease of polyunsaturated fatty acids (PUFA) and lipids,
and formate, pyruvate, glutamine, and glucose.
Lactate, glutamate, succinate, glycine and acetone significantly
increased in Pa04C TIF compared to Panc1 TIF or normal interstitial fluid. These differences in TIF cannot be explained
solely by the differences in the tumor metabolic profile as shown in Figure
3. Our data provide new insights into
changes in the metabolic secretome with induction of cachexia that may shed new
light on the cachexia cascade, and identify metabolic strategies to reverse the
syndrome. Acknowledgements
This work was supported by NIH R01 CA193365, NIH P50CA013175 and NIH P30CA06973. References
1. Argiles, JM.et. al., Nature reviews. Cancer 2014, 14 (11), 754-62.
2. Ozola ZI et. al., Pancreatology
2015, 15 (1), 19-24.
3. Fearon, KC et. al., HPB (Oxford) 2010, 12 (5), 323-4.
4. Penet, MF et. al., Clinical Cancer
Res 2015, 21 (2), 386-95.